ADVERTISEMENT

From the Desk of the CEO

James Keagy
/ Categories: CEO Blog

Standard of Care Means Pharmacists Must Control Their Own Practice

Most who read my blogs know that I don’t shy away from controversy. Indeed, I hope that these lines will be catalysts for conversations.

Let’s face it: Most of the challenges we face in our profession today are complex. Pulling one lever may help solve a problem, but it’s likely pulling several levers in the right sequence and over time that will lead to the transformation that we want.

But let’s forget transformation for just moment. When I graduated from pharmacy school my goal was simple: let me take care of patients the way I’d been trained. My wife, also a pharmacist, and I were just talking about this. She went to work in one of the busiest pharmacies in northern Virginia back at that time while I finished up training in Washington. By the time we moved back to Alabama to work in our independent pharmacy, Heather was already frustrated because she’d not had the staffing she really needed (yes, back in the mid-1990s) to take care of patients. She’d been trained to use a new point-of-care device for cholesterol monitoring and was ready to start helping her patients—only to be told by her employer that if it couldn’t be done in all their pharmacies, it wouldn’t be done in any of them. She was disenfranchised only a year into practice, and we were hopeful as we entered our own practice that we could control our own destiny.

Something has changed. Not everywhere, but in lots of places. As I travel around the country visiting pharmacists in their practices, they do not feel as though they have the autonomy within their practice to make decisions or to practice in the way they feel is best for their patients. They feel they have a prescribed list of things (protocols) that must get done, and that without the staffing to do the must things, they have no time to do the things that their professional oath tells them they should be doing to truly care for patients. And I'm talking about pharmacists in all patient care settings, not only big box pharmacies that the public most commonly sees. While this is a problem in those settings, there are some incredibly bright spots in community pharmacies large and small where I hear the opposite—pharmacists who feel they have the support and autonomy that I felt early in my career.

A pharmacist not being able to make decisions and do what they know needs to be done for the patient is a serious problem.

Pharmacists provide care.

Not pharmacies.

Not hospitals.

Not corporations.

Not venture capitalists.

Pharmacists.

We are talking about health care—individualized, personalized, customized, every-person-needs-something-different kind of care.

The business of health care does involve corporations. And we need corporations and businesses to find that balance and recognize pharmacists as health care practitioners with the autonomy to lead their own practice. 

Standard of care laws and regulations are gaining acceptance across states. These laws and regulations are quickly enabling pharmacists to lead their own practices. This means that pharmacists' practices simply can’t be the same in every location. Every pharmacist in these models will be challenged to provide care for every patient to meet the standard of care. It’s the license of the individual that is ultimately on the line. And it’s the reputation of our profession that is also on the line. It’s time for our profession to come to grips with this dilemma and collectively take action to create an environment where pharmacists can thrive regardless of the setting in which they provide care.

Feeling a little spicey. For all of pharmacy.

Previous Article Remembering September 11, 2001
Next Article We're all in this together
Print
994
Please login or register to post comments.

Featured Post

Posted: Sep 29, 2026

Remembering Jack Schlegel, former APhA CEO

APhA mourns the passing of former CEO John F. “Jack” Schlegel, PharmD. His courageous leadership helped shape our association and strengthen pharmacy’s voice. Michael Hogue reflects on Jack’s legacy and the kindness he experienced firsthand.

All Posts

Posted: Oct 8, 2026

What Canada can teach us about the pharmacy team

In his latest blog, APhA CEO Michael Hogue explores how technology, pharmacy technicians, and modernized workflows can help transform pharmacy practice and enable pharmacists to focus on the patient care services only they are trained and licensed to provide. Drawing from a visit to a high-volume community pharmacy in Quebec, Hogue highlights a care model where pharmacists concentrate on medication management, clinical decision-making, and patient consultations, while technology and qualified technicians support dispensing operations.

Posted: Sep 29, 2026

Remembering Jack Schlegel, former APhA CEO

APhA mourns the passing of former CEO John F. “Jack” Schlegel, PharmD. His courageous leadership helped shape our association and strengthen pharmacy’s voice. Michael Hogue reflects on Jack’s legacy and the kindness he experienced firsthand.

Posted: Sep 17, 2026

We're all in this together

Following the passing of former APhA President R. David Cobb, APhA CEO Michael Hogue reflects on Cobb’s enduring leadership and his belief that pharmacy is strongest when its organizations work together.

Posted: Sep 14, 2026

Standard of Care Means Pharmacists Must Control Their Own Practice

As pharmacy practice continues to evolve, pharmacists must have the autonomy to exercise their professional judgment and make decisions based on the needs of their patients. In this blog, CEO Michael Hogue explains why pharmacists must control their own practice and why professional autonomy is essential to protecting patients and advancing the profession.

Posted: Sep 11, 2026

Remembering September 11, 2001

Like many of you, I remember exactly where I was when I learned that an airplane had been intentionally flown into the World Trade Center in New York. Standing behind the counter at Morgan City Drugs, I didn’t have access to a television. However, we did have a radio, and it wasn’t hard to find a station that was covering the real-time events that morning. When the second airplane hit, we all knew that this was no accident, but an intentional attack on the very freedom we hold dear.

Voices of APhA

Perspectives & Stories from Our Staff

Posted: Oct 23, 2026

Kratom’s risks deserve our attention

Brigid Groves, PharmD, MS, Vice President, Professional Affairs, APhA

A patient seeking relief may not recognize the risks of a product within easy reach. Brigid K. Groves, PharmD, MS, APhA’s Vice President, Professional Affairs, shares why kratom and concentrated 7-OH products deserve pharmacists’ attention and how a simple conversation can help protect patients from harm.

Posted: Jul 22, 2026

Congressional update: The hurry up and wait approach

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an update on the rapidly shrinking congressional calendar and what it means for key pharmacy priorities. He explores the opportunities and challenges facing legislation such as the Main Street Pharmacy Access Act and why time may be the biggest obstacle to advancing pharmacy policy this year.

Posted: Jun 3, 2026

The bill formerly known as ECAPS

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.

Guest Spotlights

Thought Leadership & Contributions from Industry Experts

Posted: Jul 2, 2026

Deprescribing has entered the payment era

Jennifer Pruskowski, PharmD, PhD, BCPS, BCGP and Sean M. Jeffery, PharmD, BCGP, FASCP, AGSF

For years, clinicians have known that deprescribing is clinically important. Every day, health care professionals identify unnecessary medications, reduce adverse drug events, prevent falls, minimize drug interactions, and help patients navigate medication burden.

Posted: Jun 10, 2026

Offer vaccines just as strongly as last year

Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, Managing Editor, IZ Express, Immunize.org

In a new guest blog from APhA, Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, encourages pharmacists to continue giving strong vaccine recommendations and reminds the profession that vaccines remain one of the safest and most effective tools to prevent serious illness and death.

Posted: Jun 8, 2026

The Importance of Motivational Interviewing and Patient Connection

Bruce A. Berger, PhD, Professor Emeritus, Auburn University Harrison College of Pharmacy

Fifteen years ago, William Villaume and I developed our sense making approach to motivational interviewing (MI) based on Brenda Dervin's sense making theory.

Advertisement
Advertisement
Advertisement
Advertisement